α-Glucosidase is often used as a therapeutic target protein for diabetes; it is an exoenzyme that works similarly to glucoamylase, which can cut glycosidic bonds in di- and oligosaccharides, as well as aryl glucosides, to produce glucose. This evidence concerns the gene MGAM2 and diabetes mellitus.